Acutus Medical, Inc. (AFIB)
USD 0.03
(6.67%)
USD 0.03
(6.67%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.81 USD | -102.16% |
| 2022 | -1.39 USD | 67.75% |
| 2021 | -4.31 USD | 51.79% |
| 2020 | -8.94 USD | -105.52% |
| 2019 | -4.35 USD | -53.17% |
| 2018 | -2.84 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 USD | 43.59% |
| 2024 Q1 | -0.05 USD | -121.0% |
| 2023 Q1 | -0.58 USD | -209.43% |
| 2023 FY | - USD | -102.16% |
| 2023 Q3 | -0.45 USD | 28.57% |
| 2023 Q2 | -0.63 USD | -8.62% |
| 2023 Q4 | 0.26 USD | 157.78% |
| 2022 Q3 | -0.72 USD | -500.0% |
| 2022 Q2 | -0.12 USD | 91.89% |
| 2022 Q1 | -1.48 USD | -32.14% |
| 2022 FY | - USD | 67.75% |
| 2022 Q4 | 0.53 USD | 173.61% |
| 2021 FY | - USD | 51.79% |
| 2021 Q3 | -0.94 USD | 7.84% |
| 2021 Q4 | -1.12 USD | -19.15% |
| 2021 Q2 | -1.02 USD | 1.92% |
| 2021 Q1 | -1.04 USD | 0.95% |
| 2020 Q3 | -1.95 USD | -107.45% |
| 2020 Q2 | -0.94 USD | 10.48% |
| 2020 Q1 | -1.05 USD | 8.7% |
| 2020 FY | - USD | -105.52% |
| 2020 Q4 | -1.05 USD | 46.15% |
| 2019 Q1 | -0.85 USD | 0.0% |
| 2019 FY | - USD | -53.17% |
| 2019 Q4 | -1.15 USD | 38.17% |
| 2019 Q3 | -1.86 USD | -5.68% |
| 2019 Q2 | -1.76 USD | -107.06% |
| 2018 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biotricity, Inc. | -1.66 USD | -69.277% |
| Cell MedX Corp. | -0.00 USD | -561900.0% |
| Dynatronics Corporation | -1.00 USD | -181.0% |
| Nemaura Medical Inc. | -0.57 USD | -392.982% |
| PetVivo Holdings, Inc. | -0.78 USD | -260.256% |
| RetinalGenix Technologies Inc. | -0.12 USD | -2241.667% |
| Sonendo, Inc. | -0.65 USD | -332.308% |
| Telesis Bio, Inc. | -1.64 USD | -71.341% |
| Talis Biomedical Corporation | -34.12 USD | 91.764% |
| Viveve Medical, Inc. | -2.65 USD | -6.038% |